Bile acid sequestrants for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia-Reference-Cited by-同舟云学术

Bile acid sequestrants for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia

Published:2017-12-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ryan Aidan¹,Nevitt Sarah J²,Cook Paul¹

Affiliation:

1. University Hospital Southampton NHS Foundation Trust; Department of Clinical Biochemistry; 17 Tremona Road Southampton UK SO16 6YD

2. University of Liverpool; Department of Biostatistics; Block F, Waterhouse Building 1-5 Brownlow Hill Liverpool UK L69 3GL

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012896/epdf/full

Reference34 articles.

1. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers;Besseling;Atherosclerosis,2014

2. Treatment of familial hypercholesterolaemia. The United Kingdom lipid clinics study of pravastatin and cholestyramine;Betteridge;BMJ,1992

3. Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects;Davidson;Archives of Internal Medicine,1999

4. A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia;Davidson;Journal of Clinical Lipidology,2011

5. Deeks JJ Higgins JPT Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives;Molecular Pharmaceutics;2022-03-25